“It has always been our goal to provide access to a well-tolerated and effective vaccinefor as many people as possible worldwide. BioNTech is glad to be able to also supply the Taiwanese people with vaccines manufactured in theEuropean Union. In parallel, BioNTech will continue to evaluate the vaccine for use against additional mutations of concerns.”
路透社報導，據泰國衛生部4月至7月的統計資料，在完成接種2劑科興疫苗的67萬7348名醫護人員中，有618人感染2019冠狀病毒疾病（COVID-19），其中1名護理師病故，還有1人情況危急。